PMID: 6405939May 28, 1983Paper

Successful treatment of herpes labialis with topical acyclovir

British Medical Journal
A P FiddianD Dean

Abstract

A double blind, placebo controlled trial of 5% acyclovir cream, applied topically five times a day for five days, was carried out in 49 patients with recurrent herpes labialis. These patients had a total of 74 episodes, 34 of which were treated with the 5% acyclovir cream and 40 with matching placebo. First episodes and all episodes treated with acyclovir cream had significantly shorter times to formation of ulcer or crust and to complete healing (p less than 0.05 for all variables). The duration of all symptoms and proportion of patients developing itching was also reduced by acyclovir cream in first episodes, though the difference was not significant. When the patient started treatment early in the course of a first episode acyclovir cream significantly reduced the percentage of lesions progressing beyond the papular stage (p less than 0.05). Acyclovir cream is well tolerated and effective for the treatment of recurrent herpes labialis.

References

Jun 3, 1982·The New England Journal of Medicine·L CoreyK K Holmes
May 1, 1983·The Journal of Infection·A P FiddianA E Clark
Jul 1, 1982·The Journal of Infectious Diseases·S L SpruanceC S Crumpacker
Jul 20, 1982·The American Journal of Medicine·P Collins, N M Oliver

❮ Previous
Next ❯

Citations

Dec 1, 1985·Antiviral Research·D S Freestone
Jun 1, 1989·Antiviral Research·H T ZwartouwP Collins
Dec 1, 1990·Antiviral Research·S L Spruance, D J Freeman
Sep 20, 1992·The New England Journal of Medicine·R J Whitley, J W Gnann
Oct 1, 1993·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·C L Lavelle
Jan 15, 2003·Clinical Microbiology Reviews·Teresa H BaconDavid Sutton
Jan 19, 1985·British Medical Journal·D J Jeffries
Jul 6, 1985·British Medical Journal·M ShawM R Klaber
Jul 27, 1985·British Medical Journal·S KingsleyM Hantzperg
Apr 13, 1996·BMJ : British Medical Journal·P J Lamey
Apr 1, 1984·European Journal of Clinical Microbiology·E de Clercq
Jan 1, 1986·Journal of Child Psychology and Psychiatry, and Allied Disciplines·K P NunnM Cohen
Dec 10, 2016·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Fangman ChenLu Jiang
Dec 1, 1985·The British Journal of Dermatology·R H Meyrick ThomasJ D Kirby
Jan 1, 1993·Journal of Medical Virology·C R HigginsI M Leigh
Jan 1, 1993·Journal of Medical Virology·M Drummond, M Backhouse
Feb 1, 1984·Australian and New Zealand Journal of Medicine·A P Barrett
Sep 1, 1988·Contact Dermatitis·J G Camarasa, E Serra-Baldrich
Sep 28, 2002·The Journal of Infectious Diseases·Anthony Simmons
Sep 28, 2002·The Journal of Infectious Diseases·A LaiskonisE Hiltunen-Back
Jan 22, 2003·The British Journal of Dermatology·O ChosidowUNKNOWN Valaciclovir Herpes Facialis Study Group
May 1, 1989·Contact Dermatitis·M GolaA Sertoli
May 4, 2011·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Skuli SkulasonThordis Kristmundsdottir
Nov 1, 1995·The Journal of Dermatology·L P GangarosaJ M Hill
Jun 9, 1984·The Medical Journal of Australia·D O White
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·D I BernsteinS L Spruance

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.